|
|
» Article
Access Statistics
Year : 2021 | Volume: 53 | Issue Number: 3 | Page: 226-228 SHORT COMMUNICATIONCan emapalumab be life saving for refractory, recurrent, and progressive cytokine storm caused by COVID-19, which is resistant to anakinra, tocilizumab, and Janus kinase inhibitors Cure Erkan, Kucuk Adem, Cure Medine Cumhur
|
|
|
Online since 20th July '04 | |
Published by Wolters Kluwer - Medknow |